Education
About Us
Working with TipRanks
Follow Us
INVO Fertility (IVF)
NASDAQ:IVF
IVF Stock Chart & Stats
$0.93
--
Market closed
$0.93
--
Day’s Range― - ―
52-Week Range$1.32 - $299.52
Previous CloseN/A
VolumeN/A
Average Volume (3M)8.28M
Market Cap
$2.09M
Enterprise Value$17.75M
Total Cash (Recent Filing)$355.89K
Total Debt (Recent Filing)$4.23M
Price to Earnings (P/E)―
Beta0.21
Next Earnings
May 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.16
Shares Outstanding2,386,826
10 Day Avg. Volume24,408,967
30 Day Avg. Volume8,279,900
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.24
Price to Sales (P/S)0.46
P/FCF Ratio-0.95
Enterprise Value/Market Cap8.51
Enterprise Value/Revenue2.56
Enterprise Value/Gross Profit6.52
Enterprise Value/Ebitda-0.73
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationAnalyst's recommendation to upgrade shares to Buy reflects confidence in the company's revenue outlook related to its lead asset in cancer treatment.
Company StrategyThe merger of INVO Biosciences with NAYA Biosciences creates a strong focus on developing a portfolio of bifunctional antibodies.
Product DevelopmentThe company's portfolio is largely composed of bifunctional antibodies, which include promising treatments for various types of cancer.
Bears Say
Market EnvironmentRaising capital will likely take time in a particularly challenging market environment.
Regulatory ComplianceThe company received a letter from Nasdaq indicating that the company failed to file its 10-K on a timely basis and as such, no longer satisfies listing rules.
Strategic FocusThe inability of the strategy to shift focus to oncology in general and bispecifics in particular is a disappointment, in our view.
INVO Fertility News
IVF FAQ
What was INVO Fertility’s price range in the past 12 months?
INVO Fertility lowest stock price was $1.32 and its highest was $299.52 in the past 12 months.
What is INVO Fertility’s market cap?
INVO Fertility’s market cap is $2.09M.
When is INVO Fertility’s upcoming earnings report date?
INVO Fertility’s upcoming earnings report date is May 06, 2026 which is in 130 days.
How were INVO Fertility’s earnings last quarter?
INVO Fertility released its earnings results on Nov 17, 2025. The company reported -$6.16 earnings per share for the quarter, missing the consensus estimate of N/A by -$6.16.
Is INVO Fertility overvalued?
According to Wall Street analysts INVO Fertility’s price is currently Overvalued.
Does INVO Fertility pay dividends?
INVO Fertility does not currently pay dividends.
What is INVO Fertility’s EPS estimate?
INVO Fertility’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INVO Fertility have?
INVO Fertility has 2,386,826 shares outstanding.
What happened to INVO Fertility’s price movement after its last earnings report?
INVO Fertility reported an EPS of -$6.16 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.181%.
Which hedge fund is a major shareholder of INVO Fertility?
Currently, no hedge funds are holding shares in IVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
INVO Fertility
INVO Fertility is a leading provider of in vitro fertilization (IVF) services, specializing in advanced reproductive technologies to assist individuals and couples facing fertility challenges. The company operates fertility clinics across the United States, offering a comprehensive range of services including fertility assessments, IVF procedures, egg freezing, and donor egg programs. INVO Fertility is committed to providing personalized care and innovative solutions, guided by a team of experienced reproductive endocrinologists and healthcare professionals.
Technical Analysis
Ownership Overview
0.05% Insiders
0.23% Mutual Funds
10.90% Other Institutional Investors
88.76% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---